Insider · CIK 0001294596
Nancy Wysenski
Files at CYTK (CYTOKINETICS INC), ALKS (Alkermes plc.), PRVB (Provention Bio, Inc.). First filing May 10, 2023, latest May 10, 2023.
In brief
Nancy Wysenski files SEC Form 4 as director at ALKS (Alkermes plc.), and also at CYTK (CYTOKINETICS INC), PRVB (Provention Bio, Inc.). Since May 10, 2023, Nancy Wysenski has reported 0 open-market buys worth $0 and 1 open-market sell worth $1.3M, the latest filed on May 10, 2023.
A track record needs three past buys with six months of prices behind them; Nancy Wysenski has 0, so none is measured yet.
The newest scored trade: sold $1.3M of ALKS on May 9, 2023, filed May 10, 2023, scored 25 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ALKS: Alkermes plc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | Alkermes plc. | $1.3M 41,250 shares | -72% | +41% from low-3% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 9, 2023 | ALKS Alkermes plc. | 41,250 0.02% of outstanding | $1.3M | May 9, 2023 | none |
Transactions
Every row this insider has filed, 34 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +75 | $82.62 | $6,197 | 33,992 | Jul 16, 2026 |
| May 27, 2026 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +2,851 | $0.00 | $0 | 33,917 | May 27, 2026 |
| May 27, 2026 | CYTK CYTOKINETICS INC | AGrant or award Non-Qualified Stock Option (Right to Buy)derivative | +4,301 | $0.00 | $0 | 4,301 | May 27, 2026 |
| Apr 15, 2026 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +95 | $65.37 | $6,210 | 31,066 | Apr 15, 2026 |
| Jan 15, 2026 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +98 | $63.44 | $6,217 | 30,971 | Jan 16, 2026 |
| Oct 15, 2025 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +99 | $62.80 | $6,217 | 30,873 | Oct 16, 2025 |
| Jul 15, 2025 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +164 | $38.01 | $6,234 | 30,774 | Jul 16, 2025 |
| May 14, 2025 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +7,333 | $0.00 | $0 | 30,610 | May 14, 2025 |
| May 14, 2025 | CYTK CYTOKINETICS INC | AGrant or award Non-Qualified Stock Option (Right to Buy)derivative | +10,880 | $0.00 | $0 | 10,880 | May 14, 2025 |
| Apr 15, 2025 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +162 | $38.56 | $6,247 | 23,277 | Apr 16, 2025 |
| Jan 2, 2025 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +127 | $48.93 | $6,214 | 23,115 | Jan 6, 2025 |
| Oct 1, 2024 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +118 | $52.60 | $6,207 | 22,988 | Oct 3, 2024 |
| Jul 1, 2024 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +114 | $0.00 | $0 | 22,870 | Jul 3, 2024 |
| May 15, 2024 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +5,600 | $0.00 | $0 | 22,756 | May 16, 2024 |
| May 15, 2024 | CYTK CYTOKINETICS INC | AGrant or award Non-Qualified Stock Option (Right to Buy)derivative | +3,636 | $0.00 | $0 | 3,636 | May 16, 2024 |
| Jan 2, 2024 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +74 | $84.12 | $6,225 | 17,156 | Jan 3, 2024 |
| Jul 7, 2023 | ALKS Alkermes plc. | MOption exercise Ordinary Shares | +5,957 | - | - | 21,786 | Jul 10, 2023 |
| Jul 7, 2023 | ALKS Alkermes plc. | FTax withholding Ordinary Shares | -1,430 | $29.88 | $43k | 20,356 | Jul 10, 2023 |
| Jul 7, 2023 | ALKS Alkermes plc. | MOption exercise Restricted Stock Unit Awardderivative | -5,957 | - | - | 0 | Jul 10, 2023 |
| Jun 29, 2023 | ALKS Alkermes plc. | AGrant or award Non Qualified Stock Option (Right to Buy)derivative | +12,732 | $0.00 | $0 | 12,732 | Jun 30, 2023 |
| Jun 29, 2023 | ALKS Alkermes plc. | AGrant or award Restricted Stock Unit Awardderivative | +5,985 | $0.00 | $0 | 5,985 | Jun 30, 2023 |
| May 10, 2023 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 16,671 | May 18, 2023 |
| May 10, 2023 | CYTK CYTOKINETICS INC | AGrant or award Non-Qualified Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | May 18, 2023 |
| May 9, 2023 | ALKS Alkermes plc. | MOption exercise Ordinary Shares10b5-1 | +35,000 | $31.13 | $1.1M | 50,829 | May 10, 2023 |
| May 9, 2023 | ALKS Alkermes plc. | MOption exercise Ordinary Shares10b5-1 | +6,250 | $31.13 | $195k | 57,079 | May 10, 2023 |
| May 9, 2023 | ALKS Alkermes plc. | SOpen-market sale Ordinary Shares10b5-1 | -41,250 | $31.24 | $1.3M | 15,829 | May 10, 2023 |
| May 9, 2023 | ALKS Alkermes plc. | MOption exercise Non Qualified Stock Option (Right to Buy)derivative10b5-1 | -35,000 | $0.00 | $0 | 0 | May 10, 2023 |
| May 9, 2023 | ALKS Alkermes plc. | MOption exercise Non Qualified Stock Option (Right to Buy)derivative10b5-1 | -6,250 | $0.00 | $0 | 0 | May 10, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -128,981 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -22,200 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -23,000 | - | - | 0 | Apr 27, 2023 |
| Apr 27, 2023 | PRVB Provention Bio, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -33,000 | - | - | 0 | Apr 27, 2023 |
| Apr 3, 2023 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +149 | $37.71 | $5,619 | 11,671 | Apr 5, 2023 |
| Jan 3, 2023 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +126 | $44.35 | $5,588 | 11,522 | Jan 4, 2023 |
Questions about Nancy Wysenski
Answered from the filings on this page, as of the latest one.
Is Nancy Wysenski buying or selling?
Not in the last 12 months. Nancy Wysenski's latest open-market trade on SEC Form 4 was sold $1.3M of ALKS on May 9, 2023.
How did Nancy Wysenski's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nancy Wysenski has 0.
Where does Nancy Wysenski file Form 4?
Nancy Wysenski has filed Form 4 at ALKS (Alkermes plc.); CYTK (CYTOKINETICS INC); PRVB (Provention Bio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.